Raymond James & Associates’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Raymond James & Associates’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-64,300	Closed	-$84.2K	–	3994
2023 Q3	$84.2K	Hold	64,300	–	–	﹤0.01%	3628
2023 Q2	$113K	Hold	64,300	–	–	﹤0.01%	3608
2023 Q1	$108K	Buy	+64,300	New	+$167K	﹤0.01%	3636

Raymond James & Associates's MIRO Position: Q4 2023 in Review

Raymond James & Associates sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 64,300 shares — an estimated $84.2K sold.

Raymond James & Associates first reported a position in MIRO in Q1 2023 and held it in 3 quarters. The position peaked at $113K in Q2 2023. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

Raymond James & Associates reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Raymond James & Associates sold 64,300 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $84.2K.
Raymond James & Associates first reported a position in Miromatrix Medical Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Raymond James & Associates's Miromatrix Medical Inc. Common Stock position peaked at $113K in Q2 2023.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.